## Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal

**Conference**

February 23, 2026 CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA. A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at [https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz](https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz)

**About Carlsmed, Inc.**  
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

**Investor Relations**  
Caroline Corner, PhD  
IR@Carlsmed.com

**Media**  
LeAnn Burton  
Senior Director Brand Marketing  
LBurton@Carlsmed.com